Information on compatibility is available only from the pharmaceutical company for ... in 5% dextrose injection IV 200 mL/hr Clindamycin Pharmacia & Upjohn 06DPU 900 mg (30 mg/mL) in 0.45% sodium ...

This expertise in fermentation and large-scale pharmaceutical ... Lambert in 2000, Pharmacia and Upjohn in 2002, Wyeth in 2009, and Medivation in 2016. In 2015 the company also paid $17 billion ...

Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is one of the leading pharmaceutical companies having presence in Indian and global markets. The Company is a dominant ...

And STAT is a media company started by Boston Globe Media ... A 2020 STAT analysis found more than two-thirds of Congress receiving a check from pharmaceutical companies that year. More recent data ...

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...

Adding around $1.5 billion in annual sales by 2030 would be a step in the right direction for Vertex Pharmaceuticals but this wouldn't be a transformative contribution. In November, the company ...

Ionis Pharmaceuticals, Inc. engages in the development ... and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K.

CRANBURY, N.J., January 02, 2025--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare ...

LONDON, Feb 4 (Reuters) - Britain's pharmacies regulator on Tuesday tightened rules for online pharmacies' prescribing obesity drugs, ordering them to make changes to prevent people from receiving ...

1965 - The Company was incorporated on 15th December. The Company Manufacture `Boots' brand of medical and pharmaceutical products and agricultural and animal health products. The leading lines of ...

HOUSTON and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing therapies for patients with ...